HAART and the liver: friend or foe?
The overall effect of HAART on the liver is the result of the balance between hepatotoxicity and the consequences of immunoreconstitution on the evolution of HIV-associated liver diseases, particularly viral hepatitis. HAART may lead to the emergence of acute toxic hepatitis, steatosis, steatohepatitis, liver fibrosis, and noncirrhotic portal hypertension. On the other hand, HAART use has been associated with slower fibrosis progression in HIV/HCV-coinfected patients in most studies dealing with this issue. As well, an improvement of the clinical outcome of liver disease has been reported in patients taking HAART. For these reasons, the short- and mid-term effects of HAART on the liver are mostly beneficial.
Pineda
J A
JA
Unit of Infectious Diseases, Hospital Universitario de Valme, Sevilla, Spain. japineda@telefonica.net
Macías
J
J
Mira
J A
JA
Merchante
N
N
del Valle
J
J
Neukam
K I
KI
D023241:Antiretroviral Therapy, Highly Active; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008099:Liver / Q000187:drug effects*; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000209:etiology; D011379:Prognosis
AIDS. 2006 Jan 2;20(1):49-57
16327319
AIDS Res Hum Retroviruses. 2009 Apr;25(4):383-5
19320566
J Infect Dis. 2005 Nov 1;192(9):1566-76
16206071
Med Clin (Barc). 2009 Feb 21;132(6):208-13
19237003
Clin Infect Dis. 2008 Jan 1;46(1):137-43
18171229
Am J Gastroenterol. 2007 Nov;102(11):2536-40
17640321
J Acquir Immune Defic Syndr. 2006 Jun;42(2):177-82
16688096
Clin Infect Dis. 2001 Aug 15;33(4):562-9
11462196
J Antimicrob Chemother. 2007 Jan;59(1):87-91
17095528
Hepatology. 1999 Oct;30(4):1054-8
10498659
AIDS. 2007 Jan 11;21(2):187-92
17197809
Enferm Infecc Microbiol Clin. 2008 Oct;26(8):500-1
19094863
AIDS. 2008 Oct 1;22(15):1979-91
18784461
Lancet. 2003 Nov 22;362(9397):1708-13
14643119
Gut. 2009 Dec;58(12):1654-60
19625279
AIDS. 2004 Mar 26;18(5):767-74
15075511
J Hepatol. 2006 Jan;44(1):47-55
16182404
AIDS. 2008 Jan 11;22(2):203-10
18097222
AIDS. 2005 Sep 2;19(13):1375-83
16103768
Hepatology. 2007 Sep;46(3):622-30
17659577
Curr Opin Lipidol. 2001 Jun;12(3):313-9
11353335
Antivir Ther. 2008;13(1):103-7
18389904
AIDS. 2007 Oct 18;21(16):2209-16
18090048
Clin Infect Dis. 2006 Jan 15;42(2):262-70
16355339
Gastroenterology. 2008 Mar;134(3):803-11
18325393
AIDS. 2005 Mar 24;19(6):585-92
15802977
J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):168-73
17527092
AIDS. 2004 Oct 21;18(15):2039-45
15577625
World J Gastroenterol. 2009 Feb 28;15(8):996-1003
19248201
PLoS One. 2009;4(2):e4517
19223976
Clin Infect Dis. 2006 Aug 1;43(3):365-72
16804853
Clin Infect Dis. 2004 Jan 1;38(1):128-33
14679458